旧版入口
|
English Name
|
GMP
|
DMF
|
Spec.
|
Current status
|
|
Meloxicam
|
Y
|
Y
|
USP / EP
|
Commercial
|
|
Nimodipine
|
Y
|
Y
|
EP
|
Commercial
|
|
Glimepiride
|
Y
|
N
|
EP/JP
|
Commercial
|
|
Carbidopa
|
CEP to be entitled
FDA under evaluation
|
Y
|
EP/USP
|
Commercial
|
|
Calcium Polycarbophil
|
Y
|
Y
|
USP
|
Commercial
|
|
Sevelamer Carbonate
|
Y
|
N
|
In-house
|
Commercial
|
|
Sevelamer Hydrochloride
|
Y
|
N
|
In-house
|
Commercial
|
|
Sodium Rabeprazole
|
Y
|
N
|
In-house
|
Commercial
|
NOTES: All other different packaging sizes can be provided according to customer’s requirements.
Tel: 86-533-2196808,2196814. Contact Person: Mr.Wu Licheng wulicheng@gyqxsy.com； Philip Yang yanghongfei@gyqxsy.com